Should We Stop Glucagon-Like Peptide-1 Receptor Agonists Before Surgical or Endoscopic Procedures? Balancing Limited Evidence With Clinical Judgment
Methodological detailsopinion article
- Opinion article
Recommendations
As issued by the authors
Limited evidence supports the American Society of Anesthesiologists (ASA) Task Force recommendation to discontinue GLP-1 RA before surgery for potential pulmonary aspiration risk; holding GLP-1 RA may worsen glycemic control in diabetes
Pending further safety data, the authors suggest an alternative multidisciplinary approach to manage patients undergoing elective surgery
Original publication
Should We Stop Glucagon-Like Peptide-1 Receptor Agonists Before Surgical or Endoscopic Procedures? Balancing Limited Evidence With Clinical Judgment. J Diabetes Sci Technol. Published 11 March 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →